M. Le Deley

584 total citations
20 papers, 417 citations indexed

About

M. Le Deley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, M. Le Deley has authored 20 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in M. Le Deley's work include Sarcoma Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). M. Le Deley is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (3 papers) and Acute Myeloid Leukemia Research (2 papers). M. Le Deley collaborates with scholars based in France, Austria and Netherlands. M. Le Deley's co-authors include Christine Chomienne, Deborah A. Bowen, M Duarte, A. Guerci, Pierre Fenaux, MT Daniel, Sylvie Castaigné, Hartmut Link, E Archimbaud and Michael Paulussen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

M. Le Deley

16 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Le Deley France	4	346	344	110	76	35	20	417
Consuelo Rayón Spain	4	559 1.6×	582 1.7×	159 1.4×	137 1.8×	51 1.5×	6	637
Anna Ravn Landtblom Sweden	7	271 0.8×	309 0.9×	75 0.7×	55 0.7×	35 1.0×	12	386
Fabiana Gentilini Italy	10	148 0.4×	232 0.7×	37 0.3×	16 0.2×	7 0.2×	22	296
J. Catalano United Kingdom	9	114 0.3×	127 0.4×	10 0.1×	18 0.2×	8 0.2×	14	210
M. H. Schlageter France	6	84 0.2×	112 0.3×	14 0.1×	8 0.1×	8 0.2×	15	197
Nicola Cantore Italy	9	43 0.1×	84 0.2×	4 0.0×	22 0.3×	4 0.1×	14	158
D. Bowen United Kingdom	7	99 0.3×	205 0.6×	4 0.0×	26 0.3×	15 0.4×	12	286
Corinna Strupp Germany	5	75 0.2×	464 1.3×	3 0.0×	77 1.0×	34 1.0×	7	485
Y. Kim United States	6	100 0.3×	8 0.0×	17 0.2×	8 0.1×	16 0.5×	11	514
C Stainer United Kingdom	11	46 0.1×	282 0.8×	7 0.1×	49 0.6×		12	384

Countries citing papers authored by M. Le Deley

Since Specialization

Citations

This map shows the geographic impact of M. Le Deley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Le Deley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Le Deley more than expected).

Fields of papers citing papers by M. Le Deley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Le Deley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Le Deley. The network helps show where M. Le Deley may publish in the future.

Co-authorship network of co-authors of M. Le Deley

This figure shows the co-authorship network connecting the top 25 collaborators of M. Le Deley. A scholar is included among the top collaborators of M. Le Deley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Le Deley. M. Le Deley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wallet, Jennifer, L. Chaigneau, Nelly Firmin, et al.. (2024). 1718O EREMISS trial: A double-blind placebo (PBO)-controlled randomised trial assessing efficacy/safety of regorafenib (REGO) as maintenance therapy after 1st line doxorubicin-based chemotherapy in advanced soft-tissue sarcoma (ASTS) patients (pts). Annals of Oncology. 35. S1030–S1030. 1 indexed citations

2.

Vanlemmens, Laurence, Claudia Lefeuvre‐Plesse, Thomas Mulliez, et al.. (2024). LBA12 eMouvoir: Randomised phase III trial evaluating the impact of a personalized and remote physical activity (PA) for breast cancer survivors (BCS). Results on the quality of life (QoL). Annals of Oncology. 35. S1206–S1206.

3.

Deley, M. Le, et al.. (2023). 181P Male breast cancer (MBC): Familial history (FH), clinicopathological (CP) characteristics, oncogenetic (OG) testing and outcome in a cohort of 98 patients (pts). ESMO Open. 8(1). 101458–101458. 1 indexed citations

4.

Bonvalot, S., et al.. (2022). 1512P Pain in patients with desmoid fibromatosis (DF). Annals of Oncology. 33. S1238–S1238. 1 indexed citations

5.

Deley, M. Le, et al.. (2022). Retour d'expérience sur le projet de chaînage entre les données hospitalières du Centre Oscar Lambret et les fichiers de décès de l'Insee. Revue d Épidémiologie et de Santé Publique. 70. S67–S68.

6.

Lartigau, É., et al.. (2022). Estimation de la survie globale à partir des données administratives hospitalières avec intégration des données de décès de l'INSEE : l'expérience du Centre Oscar Lambret.. Revue d Épidémiologie et de Santé Publique. 70. S96–S97.

7.

Blay, Jean‐Yves, S. Bonvalot, Antoîne Italiano, et al.. (2021). 1522MO Hormonal contraception and pregnancy and risk of progression or relapse in desmoid-type fibromatosis (DF). Annals of Oncology. 32. S1112–S1112. 1 indexed citations

8.

Bosc, Romain, et al.. (2020). Impact of the COVID -19 pandemic on the organisation of breast reconstruction in France. Journal of Plastic Reconstructive & Aesthetic Surgery. 74(3). 644–710. 1 indexed citations

9.

Hudry, Delphine, et al.. (2019). EP1281 Total parietal peritonectomy: what morbidity? and which sites of recurrence?. A646.1–A646. 1 indexed citations

10.

Giard, S., et al.. (2019). Abstract P5-16-04: Evaluation of autologous fat grafting local morbidity (fat necrosis and biopsy rates) in breast reconstruction after breast cancer: A retrospective study on 257 patients in Oscar Lambret Center. Cancer Research. 79(4_Supplement). P5–16. 1 indexed citations

11.

Piperno‐Neumann, Sophie, M. Le Deley, Perrine Marec‐Bérard, et al.. (2014). Zoledronate Does not Reduce the Risk of Treatment Failure in Osteosarcoma: Results of the French Multicentre Os2006 Randomised Trial. Annals of Oncology. 25. iv494–iv494. 3 indexed citations

12.

Oberlin, O., M. Le Deley, Uta Dirksen, et al.. (2011). Randomized comparison of VAC versus VAI chemotherapy (CT) as consolidation for standard risk (SR) Ewing sarcoma tumor (ES): Results of the Euro-EWING.99-R1 trial.. Journal of Clinical Oncology. 29(15_suppl). 9517–9517. 10 indexed citations

13.

Owens, Cormac, et al.. (2011). The management of pulmonary nodules at diagnosis in patients with Ewing sarcoma (ES).. Journal of Clinical Oncology. 29(15_suppl). 9527–9527. 1 indexed citations

14.

Ladenstein, Ruth, Ulrike Pötschger, M. Le Deley, et al.. (2009). A prognostic score at diagnosis for Ewing tumor patients with metastatic disease at extrapulmonary sites. Journal of Clinical Oncology. 27(15_suppl). 10544–10544. 1 indexed citations

15.

Deley, M. Le, A Rosolen, David A. Williams, et al.. (2009). Prognostic factors in childhood anaplastic large cell lymphoma (ALCL): results of the ALCL99 Study. Research Padua Archive (University of Padua). 1 indexed citations

16.

Grill, Jacques, Stephen P. Lowis, Didier Frappaz, et al.. (2007). Phase II study of the combination of cisplatin + temozolomide in malignant glial tumours in children and adolescents at diagnosis or in relapse (cistem2/nct00147160). Journal of Clinical Oncology. 25(18_suppl). 9543–9543.

17.

Vassal, Gilles, Birgit Geoerger, M. Le Deley, et al.. (2006). ITCC phase II study of imatinib mesylate in children with solid tumors expressing imatinib-sensitive tyrosine kinase receptors. Journal of Clinical Oncology. 24(18_suppl). 9003–9003. 1 indexed citations

18.

Habrand, Jean‐Louis, et al.. (2004). Carcinoma of the nasopharynx in children and adolescents treated with initial chemotherapy (CT) followed by adapted doses of radiotherapy (RT). International Journal of Radiation Oncology*Biology*Physics. 60(1). S247–S247. 4 indexed citations

19.

Fenaux, Pierre, M. Le Deley, Sylvie Castaigné, et al.. (1993). Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood. 82(11). 3241–3249. 16 indexed citations

20.

Fenaux, Pierre, M. Le Deley, Sylvie Castaigné, et al.. (1993). Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood. 82(11). 3241–3249. 373 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact